Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

<p>Abstract</p> <p>Background</p> <p>Prognostic factors in locally advanced breast cancer treated with neoadjuvant chemotherapy differ from those of early breast cancer. The purpose of this study was to identify the clinical significance of potential predictive and prog...

Full description

Bibliographic Details
Main Authors: Kim Dong-Wan, Han Wonshik, Chie Eui, Lee Se-Hoon, Kim Jee, Oh Do-Youn, Kim Hee-Jun, Im Seock-Ah, Keam Bhumsuk, Moon Woo, Kim Tae-You, Park In, Noh Dong-Young, Heo Dae, Ha Sung, Bang Yung-Jue
Format: Article
Language:English
Published: BMC 2007-11-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/7/203

Similar Items

Similar Items